Results 121 to 130 of about 19,810 (202)

Reduced-frequency bictegravir, emtricitabine, and tenofovir alafenamide in virologically suppressed adults with HIV: a single-centre randomised phase 2 pilot trial in Spain. [PDF]

EClinicalMedicine
Chivite I, Moraga E, Sempere A, Vicens-Artés S, Callau P, Rovira C, Hurtado C, De Nicoló A, Sánchez-Molina A, Torres B, Blanch J, Alcamí J, Blanco JL, D'Avolio A, Sánchez-Palomino S, De Lazzari E, Martínez E.   +16 more
europepmc   +1 more source

Editorial: Tenofovir Alafenamide Versus Entecavir for Hepatitis B Surface Antigen Decline-A Step Toward Functional Cure or a Marginal Margin? [PDF]

Aliment Pharmacol Ther
Hsu YC, Yu ML.
europepmc   +1 more source

Successful Treatment of Progressive Multifocal Leukoencephalopathy With Tenofovir Alafenamide Fumarate. [PDF]

Neurol Neuroimmunol Neuroinflamm
Torkildsen Ø, Bru ANS, Behzadi GIN, Myhr KM.   +3 more
europepmc   +1 more source

Differential Hepatitis B Surface Antigen Glycan Isomer Kinetics Between Tenofovir Alafenamide and Entecavir: Hepatocellular Carcinoma Risk Stratification in Hepatitis B e Antigen-Positive Patients. [PDF]

J Viral Hepat
Kita Y, Murata A, Nago H, Yamaguchi M, Kato Y, Om R, Terai Y, Ikeda Y, Sato S, Sato S, Shimada Y, Genda T.   +11 more
europepmc   +1 more source

Tenofovir alafenamide: safer, but questions remain

The Lancet HIV, 2016
Boyd, MA, Cooper, DA
openaire   +3 more sources

Population pharmacokinetics of tenofovir alafenamide delivered via an annual subdermal implant in South African women. [PDF]

Sci Rep
Beliveau M, Chang C, Lewis L, Letsoalo MP, Karim QA, Karim SSA, Marzinke MA, Moss JA, Gengiah TN, Baum MM.   +9 more
europepmc   +1 more source

Efficacy and Safety of Switching from Entecavir to Tenofovir Alafenamide in Chronic Hepatitis B: A Multicenter Randomized Trial in Korea. [PDF]

Gut Liver
Shin H, Hur MH, Baek YH, Lee CK, Cho YK, Lee JS, Jeong JY, Jung YJ, Kim JK, Kim MY, Seo YS, Chung WJ, Koh MS, Kim JH, Lee YB, Cho EJ, Lee JH, Yu SJ, Yoon JH, Kim YJ.   +19 more
europepmc   +1 more source

Efficacy and safety of tenofovir alafenamide versus tenofovir disoproxil in chronic hepatitis b: a systematic review and meta-analysis of randomized controlled trials. [PDF]

BMC Infect Dis
Dar MS, Ovais H, Khan AW, Ishaq S, Saleem YM, Azhar SD, Affan M, Rehman Z, Athar F, Fatima T, Zahid J, Ali S, Ul Ain N, Surani S, Asghar MS, Ahmed KAHM.   +15 more
europepmc   +1 more source

Renal outcomes with dolutegravir plus lamivudine versus bictegravir/emtricitabine/tenofovir alafenamide in ART-naive adults with HIV. [PDF]

AIDS
Zhao D, Sun L, Cen P, He Y, Zhao F, Li X, Luo Y, Xiao X, Liu C, Jiang Y, Wu H, Gong W, Li Y, Liu J.   +13 more
europepmc   +1 more source

Editorial: Tenofovir Alafenamide Versus Entecavir for Hepatitis B Surface Antigen Decline-A Step Towards Functional Cure or a Marginal Margin? Authors' Reply. [PDF]

Aliment Pharmacol Ther
Kumada T, Atsukawa M, Arai T, Toyoda H, Tanaka J.   +4 more
europepmc   +1 more source